Skip to main content
An official website of the United States government

Breast Cancer Steering Committee Roster

The Breast Cancer Steering Committee (BCSC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult breast cancer. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The BCSC's membership comprises NCTN group representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.



Shelley Hwang, M.D., M.P.H.
Duke University Medical Center 
Durham, NC

Antonio C. Wolff, M.D., FACP, FASCO
Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center 
Baltimore, MD

Kathy D. Miller, M.D. [Chair Emeritus]
Indiana University Simon Cancer Center 
Indianapolis, IN



Vandana Abramson, M.D.
Vanderbilt University Ingram Cancer Center
Nashville, TN

Sunil Badve, M.B.B.S., M.D., FRCPath.
Emory University School of Medicine
Atlanta, GA

Karla Ballman, Ph.D.
Weill Cornell Medical College
New York, NY

Lisa Carey, M.D.
University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, NC

Stephen Chia,  M.D.
British Columbia Cancer Agency
Vancouver, BC, Canada

Angela DeMichele, M.D., M.S.C.E.
University of Pennsylvania Perelman Center for Advanced Medicine
Philadelphia, PA

Jared Foster, Ph.D.
National Cancer Institute
Bethesda, MD

Jami Fukui, M.D.
University of Hawai'i Cancer Center 
Honolulu, HI

Elizabeth Garrett-Mayer, PhD
American Society of Clinical Oncology
Alexandria, VA

Lisa R. Hayes, J.D.
Pink-4-Ever Ending Disparities
Indianapolis, IN

Larissa Korde, M.D., M.P.H.
National Cancer Institute
Bethesda, MD

Stanley Lipkowitz, M.D., Ph.D.
National Cancer Institute
Bethesda, MD

Eleftherios P. Mamounas, M.D., M.P.H.
University of Florida Health Cancer Center 
Orlando, FL

Ben Ho Park, M.D., Ph.D.
Vanderbilt University Ingram Cancer Center
Nashville, TN

Ann H. Partridge, M.D., M.P.H.
Dana-Farber Cancer Institute
Boston, MA

Lajos Pusztai, M.D., D.Phil.
Yale University
New Haven, CT

Eileen Rakovitch, M.D., M.Sc.
Sunnybrook Health Sciences Centre
Toronto, ON, Canada

Kathryn Ruddy, M.D.
Mayo Clinic
Rochester, MN

Priyanka Sharma, M.D.
University of Kansas Medical Center
Westwood, KS

Mary Lou Smith, J.D., M.B.A.
Research Advocacy Network
Plano, TX

Alyssa Throckmorton, M.D., FACS
Baptist Memorial Health System/Mid-South MU NCORP
Memphis, TN

Sara Tolaney, M.D., M.P.H.
Dana-Farber Cancer Institute
Boston, MA

Julia White, M.D.
Ohio State University 
Columbus, OH

Richard C. Zellars, M.D.
Indiana University 
Indianapolis, IN

Fengmin Zhao, Ph.D., M.H.S.
Harvard University Medical School
Boston, MA

NCI CCCT Program Director

Elena Schwartz, Ph.D.


  • Updated: